New York State Common Retirement Fund’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.7M | Buy |
312,841
+38,422
| +14% | +$700K | 0.01% | 1017 |
|
2025
Q1 | $5.44M | Buy |
274,419
+30,400
| +12% | +$603K | 0.01% | 1011 |
|
2024
Q4 | $4.19M | Sell |
244,019
-11,550
| -5% | -$198K | 0.01% | 1162 |
|
2024
Q3 | $5.11M | Buy |
255,569
+7,872
| +3% | +$157K | 0.01% | 1094 |
|
2024
Q2 | $2.77M | Buy |
247,697
+11,577
| +5% | +$129K | ﹤0.01% | 1349 |
|
2024
Q1 | $1.56M | Buy |
236,120
+149,468
| +172% | +$986K | ﹤0.01% | 1572 |
|
2023
Q4 | $392K | Buy |
86,652
+24,033
| +38% | +$109K | ﹤0.01% | 2192 |
|
2023
Q3 | $224K | Buy |
62,619
+571
| +0.9% | +$2.04K | ﹤0.01% | 2375 |
|
2023
Q2 | $229K | Sell |
62,048
-30,055
| -33% | -$111K | ﹤0.01% | 2433 |
|
2023
Q1 | $305K | Sell |
92,103
-37,727
| -29% | -$125K | ﹤0.01% | 2420 |
|
2022
Q4 | $504K | Sell |
129,830
-170
| -0.1% | -$660 | ﹤0.01% | 2307 |
|
2022
Q3 | $316K | Buy |
130,000
+1,700
| +1% | +$4.13K | ﹤0.01% | 2565 |
|
2022
Q2 | $254K | Buy |
+128,300
| New | +$254K | ﹤0.01% | 2685 |
|
2021
Q3 | – | Sell |
-478
| Closed | -$1K | – | 3328 |
|
2021
Q2 | $1K | Sell |
478
-40,022
| -99% | -$83.7K | ﹤0.01% | 3357 |
|
2021
Q1 | $71K | Hold |
40,500
| – | – | ﹤0.01% | 3149 |
|
2020
Q4 | $79K | Hold |
40,500
| – | – | ﹤0.01% | 3110 |
|
2020
Q3 | $97K | Hold |
40,500
| – | – | ﹤0.01% | 2931 |
|
2020
Q2 | $119K | Hold |
40,500
| – | – | ﹤0.01% | 2862 |
|
2020
Q1 | $117K | Hold |
40,500
| – | – | ﹤0.01% | 2703 |
|
2019
Q4 | $162K | Hold |
40,500
| – | – | ﹤0.01% | 2822 |
|
2019
Q3 | $180K | Buy |
40,500
+37,900
| +1,458% | +$168K | ﹤0.01% | 2823 |
|
2019
Q2 | $10K | Hold |
2,600
| – | – | ﹤0.01% | 3228 |
|
2019
Q1 | $10K | Hold |
2,600
| – | – | ﹤0.01% | 3148 |
|
2018
Q4 | $6K | Sell |
2,600
-18,500
| -88% | -$42.7K | ﹤0.01% | 3178 |
|
2018
Q3 | $131K | Hold |
21,100
| – | – | ﹤0.01% | 2994 |
|
2018
Q2 | $95K | Buy |
+21,100
| New | +$95K | ﹤0.01% | 3093 |
|